day 2: prof john bridgewater - trials immunotherapy etc
Published 3 months ago • 189 plays • Length 20:53Download video MP4
Download video MP3
Similar videos
-
15:43
day 1: john bridgewater - targeted therapies immunotherapies
-
20:01
the abc trials: what have they taught us? - ammf 2022 conference - day 2
-
25:06
integrating genomic signals into clinical trial... - john bridgewater, ucl, uk (d3p14)
-
3:16
mariposa-2: second interim os of amivantamab and chemotherapy in egfr-m nsclc
-
29:24
19 principles of immunotherapy: part 2 cancer immune evasion
-
6:37
claire harrison, md, on the freedom2 study in myelofibrosis
-
28:56
tumor talks 8.26.24
-
24:19
0102. meteoroid and cosmog clinical trials for mogad treatments
-
19:50
molecular profiling – its growing importance and how can uk and european cca patients access it?
-
1:49
early breast cancer: do we need chemotherapy in low genomic/high clinical risk (er /her2-)?
-
5:01
keynote-522: final os findings of pembrolizumab and chemotherapy in tnbc
-
0:31
cancer immunotherapy program: 30-second spot
-
29:34
immunotherapy
-
22:37
overcoming hormone therapy resistance with sarki abdulkadir, md, phd
-
22:36
new immunotherapy treatments for breast cancer presented by john smith ii, md
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
2:10
genomic factors underlying resistance to immunotherapy in newly diagnosed multiple myeloma
-
4:32
the 2nd immune and cellular therapies in multiple myeloma workshop
-
4:45
immunotherapy video 2 mp4
-
0:41
professor wainwright explains how liquid biopsies will help brain cancer treatments.